Gonadal hormones and stroke risk: PCOS as a case study

Area of Science:

• Neurology
• Endocrinology
• Reproductive Health

Background:

• Stroke incidence and outcomes show significant sex-based differences, influenced by age and gonadal hormones.
• Declining estrogen levels in post-menopausal or aged females correlate with increased stroke risk.
• Early menopause also presents an elevated stroke risk, indicating gonadal hormones regulate stroke risk irrespective of age.

Purpose of the Study:

• To review the impact of prolonged gonadal hormone dysfunction in polycystic ovarian syndrome (PCOS) on stroke risk.
• To examine the role of hyperandrogenism and metabolic comorbidities associated with PCOS in stroke pathogenesis.

Main Methods:

• Literature review focusing on studies investigating PCOS, gonadal hormone dysfunction, hyperandrogenism, metabolic syndrome, and stroke.
• Analysis of existing research on the mechanisms linking hormonal imbalances in PCOS to cerebrovascular events.

Main Results:

• Polycystic ovarian syndrome (PCOS) is characterized by chronic hormonal dysfunction, including hyperandrogenism.
• Hyperandrogenism and associated metabolic comorbidities (e.g., insulin resistance, obesity) in PCOS patients are linked to increased stroke risk.
• Evidence suggests a direct correlation between the severity of hormonal imbalance in PCOS and cerebrovascular disease.

Conclusions:

• Gonadal hormone dysregulation, particularly hyperandrogenism in PCOS, significantly increases stroke risk in women.
• Metabolic comorbidities exacerbate the stroke risk associated with PCOS.
• Further research is warranted to develop targeted preventive and therapeutic strategies for stroke in women with PCOS.